The Scientist - Home

While antibiotics given in the first week of life reduce vaccine responses at 15 months, probiotics might counteract these effects.

New research links early-life exposure to a common gut bacteria's toxin (colibactin) to rising early-onset colorectal cancer rates. Discover how childhood exposures leave genetic imprints.

A newly identified DNA epigenetic marker, 5-formylcytosine, regulates gene expression during early embryo development.

Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets to treat obesity and metabolic diseases.

Andrew Smith’s research on slug secretions yields new insights into synthetic adhesives that may one day replace medical stitches and staples.

For biologists like Heiko Jansen, grizzly bears offer a fascinating opportunity to analyze seasonal metabolic changes relevant to human health and disease.

The tardigrade’s unusual body plan and resistance to harsh conditions provide researchers like Bob Goldstein with a creative perspective on animal biology.

Scientists created ‘venom maps’ to predict Russell’s viper venom profiles, which could help clinicians tailor efficient snakebite treatments.

A common gastrointestinal cancer drug that crosses the blood-brain barrier showed promise in patients with aggressive high-grade gliomas.

A new study shows that sound isn’t just heard by the ears. Sound waves altered gene expression and influenced fat cell differentiation in culture.

Combining multiple vaccines may trigger stronger immune responses in fewer shots, potentially improving the efficacy of immunization programs.

Artificial intelligence and phylogenetics helped scientists revise the evolutionary timeline of bacteria.